SEC Filings | EyePoint Pharmaceuticals

Form	Description	Filing date	View
10-Q	Quarterly report which provides a continuing view of a company's financial position	Aug 05, 2020	View HTML 0001564590-20-036429.pdf 0001564590-20-036429.rtf 0001564590-20-036429.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
8-K	Report of unscheduled material events or corporate event	Aug 05, 2020	View HTML 0001564590-20-036461.pdf 0001564590-20-036461.rtf 0001564590-20-036461.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	Aug 05, 2020	View HTML 0001193125-20-210092.pdf 0001193125-20-210092.rtf
8-K	Report of unscheduled material events or corporate event	Aug 06, 2020	View HTML 0001564590-20-037729.pdf 0001564590-20-037729.rtf 0001564590-20-037729.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
8-K	Report of unscheduled material events or corporate event	Aug 12, 2020	View HTML 0001193125-20-217649.pdf 0001193125-20-217649.rtf 0001193125-20-217649.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
8-K	Report of unscheduled material events or corporate event	Aug 20, 2020	View HTML 0001564590-20-040715.pdf 0001564590-20-040715.rtf 0001564590-20-040715.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
4	Statement of changes in beneficial ownership of securities	Aug 26, 2020	View HTML 0001562180-20-005659.pdf 0001562180-20-005659.rtf 0001562180-20-005659.xls
4	Statement of changes in beneficial ownership of securities	Sep 09, 2020	View HTML 0001562180-20-005930.pdf 0001562180-20-005930.rtf 0001562180-20-005930.xls
8-K	Report of unscheduled material events or corporate event	Sep 15, 2020	View HTML 0001564590-20-043596.pdf 0001564590-20-043596.rtf 0001564590-20-043596.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
PRE 14A	A preliminary proxy statement providing notification matters to be brought to a vote	Oct 06, 2020	View HTML 0001564590-20-045941.pdf 0001564590-20-045941.rtf 0001564590-20-045941.xls

Data provided by Kaleidoscope.